A clinical trial to study the effect of two drugs etomidate and propofol in patients with psychiatric illness undergoing electroconvulsive therapy
Phase 4
- Conditions
- Health Condition 1: F30-F39- Mood [affective] disorders
- Registration Number
- CTRI/2023/09/057699
- Lead Sponsor
- KMCT MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 ASA I and II
Exclusion Criteria
1 Known allergy to the studying drug
2 Patients having neuromuscular disorders,cardiovascular diseases and epilepsy
3 pregnancy
4 Major sickness like sevre bronchial asthma
5 patient refusal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method haemodynamic responses includes changes in heart rate,mean arterial pressure,systolic blood pressure,rate pressure productTimepoint: 15 months
- Secondary Outcome Measures
Name Time Method adverse effects between etomidate & propofolTimepoint: 15 months;seizure durationTimepoint: 15 months